López-Álvarez, M.; González-Aguilera, C.; Moura, D.S.; Sánchez-Bustos, P.; Mondaza-Hernández, J.L.; Martín-Ruiz, M.; Renshaw, M.; Ramos, R.; Castilla, C.; Blanco-Alcaina, E.;
et al. Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas. Int. J. Mol. Sci. 2023, 24, 680.
https://doi.org/10.3390/ijms24010680
AMA Style
López-Álvarez M, González-Aguilera C, Moura DS, Sánchez-Bustos P, Mondaza-Hernández JL, Martín-Ruiz M, Renshaw M, Ramos R, Castilla C, Blanco-Alcaina E,
et al. Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas. International Journal of Molecular Sciences. 2023; 24(1):680.
https://doi.org/10.3390/ijms24010680
Chicago/Turabian Style
López-Álvarez, María, Cristina González-Aguilera, David S. Moura, Paloma Sánchez-Bustos, José L. Mondaza-Hernández, Marta Martín-Ruiz, Marta Renshaw, Rafael Ramos, Carolina Castilla, Elena Blanco-Alcaina,
and et al. 2023. "Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas" International Journal of Molecular Sciences 24, no. 1: 680.
https://doi.org/10.3390/ijms24010680
APA Style
López-Álvarez, M., González-Aguilera, C., Moura, D. S., Sánchez-Bustos, P., Mondaza-Hernández, J. L., Martín-Ruiz, M., Renshaw, M., Ramos, R., Castilla, C., Blanco-Alcaina, E., Hindi, N., & Martín-Broto, J.
(2023). Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas. International Journal of Molecular Sciences, 24(1), 680.
https://doi.org/10.3390/ijms24010680